Product Dossier
RILUCOR
Product Dossier for RILUCOR (riluzole 50 mg, Pharmacor). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: Pharmacor
- Active ingredient: riluzole 50 mg
- Therapeutic area: Neurology
- Same area: GILENYA
- Same area: RIVOTRIL
What it is
RILUCOR is a riluzole 50 mg film-coated tablet.
Regulatory history
RILUCOR riluzole 50 mg film-coated tablet in blister pack was first registered on the ARTG on 4 June 2014. A bottle presentation of RILUCOR riluzole 50 mg film-coated tablet was registered on the ARTG on 25 March 2022. ---
*Note: The provided source documents contain limited information about RILUCOR. To obtain complete information about approved indications, dosing, safety warnings, contraindications, and PBS listing status, please consult the Australian Therapeutic Goods Administration (TGA) database, the product's approved Australian Product Information document, or the Pharmaceutical Benefits Scheme (PBS) website.*